Genelux Corporation Reports Third Quarter 2024 Financial Results and Provides General Business Updates

WESTLAKE VILLAGE, Calif., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced financial results for the third quarter of 2024 and provided general business updates.

Read more at globenewswire.com